Solute Carrier Family 6 Member 1 (SLC6A1) Antibody from ABBEXA LTD

Search, find, compare suppliers for anti-Solute Carrier Family 6 Member 1 (SLC6A1) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificitySolute Carrier Family 6 Member 1 (SLC6A1)
Clonepolyclonal
Host SpeciesRabbit
Reactive Specieshuman, mouse, rat
Isotypen/a
Formataffinity purified
Size50 µg, 100 µg,
Concentrationn/a
ApplicationsELISA, WB
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionSLC6A1 antibody is a Rabbit polyclonal against SLC6A1.
ImmunogenSynthesized peptide derived from the Internal region of human GABA T-1.
Other NamesSLC6A1, GABATR, GABT1, GAT1, Sodium- and chloride-dependent GABA transporter 1, GAT-1, Solute carrier family 6 member 1, SLC6A1, SLC6A1, SLC6A1 , SLC6A1 , GABATR, GABATR, GABATR , GABATR , GABT1, GABT1, GABT1 , GABT1 , GAT1, GAT1, GAT1 , GAT1 , Sodium- and chloride-dependent GABA transporter 1, Sodium- and chloride-dependent GABA transporter 1, Sodium- and chloride-dependent GABA transporter 1 , Sodium- and chloride-dependent GABA transporter 1 , GAT-1, GAT-1, GAT-1 , GAT-1 , Solute carrier family 6 member 1, Solute carrier family 6 member 1, Solute carrier family 6 member 1 , Solute carrier family 6 member 1
Gene, Accession #SLC6A1, Gene ID: 6529, UniProt: P30531
Catalog #abx327828
Priceplease inquire
Order / More InfoSolute Carrier Family 6 Member 1 (SLC6A1) Antibody from ABBEXA LTD
Product Specific Referencesn/a
ABBEXA LTD
ABBEXA LTD
ABBEXA LTD
181 Cambridge Science Park
Cambridge, CB4 0GJ UK
P: +44 (0) 1223 755950

Customer Service: info@abbexa.com
Technical Support: support@abbexa.com
Orders: orders@abbexa.com

https://www.abbexa.com

U.S. Office
118 Eldridge Rd, Suite C,
Sugar Land, TX 77478 USA
Telephone: +1 832 327 7413

Netherlands Office
Abbexa BV
Wattstraat 54 2723 RD,
Zoetermeer,Netherlands
Telephone: +44 (0) 1223 755950


Profile of ABBEXA LTD
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.